who we are
A Message From Our Chief Compliance Officer
Compliance is at the center of everything we do. At Amarin, we believe in developing important therapies for our patients and conducting ourselves with the highest ethical standards in carrying out our mission to improve cardiovascular health.
By conducting our business with the highest ethical standards, we safeguard our patients, respect the independency of HCPs and protect Amarin’s reputation.
Jonathan Provoost
Working at Amarin
Working with Suppliers & Partners
Working with Healthcare Professionals & Healthcare Organizations
Working with Governments
Transparency Reporting
At Amarin, we are committed to acting with openness and transparency during all our interactions with Healthcare Professionals and other relevant decision makers, Healthcare Organizations, Patient Organizations and members of the public.
We support and work with the Healthcare Community, whose input and advice play an important role in supporting patient outcomes. You can find details of the Transfers of Value that we have made for the following countries by clicking on the links below.
- Europe: https://www.amarincorp.eu/about-us/working-with-our-partners
- Belgium: Transparency Register - beTransparent
- France: Transparency Health (sante.gouv.fr)
- Netherlands: Stichting Transparantieregister Zorg
- Portugal: Transparência e Publicidade - Plataforma de comunicações - INFARMED, I.P.
- Sweden: Search for open reporting of transfers of value (lif.se)
- United Kingdom: https://www.amarincorp.co.uk/amarin-uk/transparency
- United States: https://openpaymentsdata.cms.gov/search
©2025 Amarin Pharmaceuticals Ireland Limited. All rights reserved.
AMARIN, VASCEPA, VAZKEPA and REDUCE-IT names and logos are trademarks of Amarin Pharmaceuticals Ireland Limited. | ALL-NP-00014 1/23
Get In Touch
Whether you’re a patient, a healthcare professional or a job seeker, you can find the best way to contact us from the options below. We’d love to hear from you:
Follow Us
Follow Amarin on our social channels for the latest company news, product campaigns and industry updates:
